At Gilead, a science company that develops innovative treatments with the mission of providing the best solutions to life-threatening diseases, Banu Yeşilova was appointed as the Hepatology Business Unit Director as of September 1.
Banu Yeşilova, who has more than 20 years of experience in the health sector, has served as a sales manager in the field of hepatology as well as marketing positions in the fields of infection and HIV in Gilead since 2016. Yeşilova started her professional career in 2002 as a sales representative at Sanovel İlaç. He then worked in sales and marketing at Novartis in different positions for 10 years.
Yeşilova graduated from the Biology Department of Istanbul University in 2002, and has an MBA degree from the Business Administration Institute of the same university.
